GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine Congress - Geovax Labs (NASDAQ:GOVXW), Geovax Labs (NASDAQ:GOVX)
80% Survival in Nonhuman Primates Observed in a Lethal Challenge Model ATLANTA, GA, Nov. 30, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (NASDAQ:GOVX), a biotechnology company developing